Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034305 · ClinicalTrials.gov registry record
Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 7
- Enrollment target
NCT02034305 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 7 participants.
The verdict
NCT02034305 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine whether airway clearance is augmented by high frequency chest wall oscillation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01 |
| Est. Completion | 2021-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02034305
The ClinicalTrials.gov registry entry for NCT02034305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02034305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02034305 about?
NCT02034305 is a clinical study titled "Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy". This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine...
What is the current status of trial NCT02034305?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-01. Estimated completion is 2021-01-01.
Who is sponsoring clinical trial NCT02034305?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.